Article info
PDFCardiorenal syndrome
Original article
Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
- Correspondence to Marianne C Verhaar, Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands; m.c.verhaar{at}umcutrecht.nl
Citation
Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
Publication history
- Accepted September 28, 2010
- First published November 11, 2010.
Online issue publication
December 10, 2010
Article Versions
- Previous version (11 November 2010).
- You are viewing the most recent version of this article.
Web Only Data for hrt.2010.194654
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.